Alberto Fresa is an early-career hematologist and researcher specialized in hematologic malignancies. He completed his residency in Hematology at Fondazione Policlinico Universitario “A. Gemelli” IRCCS in Rome, Italy, and earned a Ph.D. in Oncological Sciences from the Università Cattolica del Sacro Cuore, also in Rome. Currently, he serves as a hematologist oncologist at the National Cancer Institute - IRCCS - Fondazione "G. Pascale" in Naples, Italy, where he focuses on the treatment of patients with hematologic malignancies, particularly lymphoproliferative disorders. Dr. Fresa is actively engaged in scientific research on lymphoproliferative disorders, targeted and cellular therapies, and translational medicine, having authored over 40 peer-reviewed publications. He has contributed as a sub-investigator in phase I, II, and III clinical trials, in addition to several self-funded initiatives. Furthermore, Dr. Fresa serves as a peer reviewer for several scientific journals, including Annals of Hematology, Frontiers in Oncology, and Hematology Reports.
Alberto Fresa is an early-career hematologist and researcher specialized in hematologic malignancies. He completed his residency in Hematology at Fondazione Policlinico Universitario “A. Gemelli” IRCCS in Rome, Italy, and earned a Ph.D. in Oncological Sciences from the Università Cattolica del Sacro Cuore, also in Rome. Currently, he serves as a hematologist oncologist at the National Cancer Institute - IRCCS - Fondazione "G. Pascale" in Naples, Italy, where he focuses on the treatment of patients with hematologic malignancies, particularly lymphoproliferative disorders. Dr. Fresa is actively engaged in scientific research on lymphoproliferative disorders, targeted and cellular therapies, and translational medicine, having authored over 40 peer-reviewed publications. He has contributed as a sub-investigator in phase I, II, and III clinical trials, in addition to several self-funded initiatives. Furthermore, Dr. Fresa serves as a peer reviewer for several scientific journals, including Annals of Hematology, Frontiers in Oncology, and Hematology Reports.